BIT 0.00% 3.0¢ biotron limited

glaxosmithkline has interest in biotron ? hmm

  1. 45 Posts.
    The GSK Medicines Research
    Unit is currently involved in a
    clinical trial relating to chronic
    Hepatitis C virus.
    http://www.biotron.com.au/ftp/BIT225-003.pdf


    Dr Michelle Miller, BSc, MSc, PhD
    Managing Director

    Dr Miller has over 20 years in the bioscience industry, with extensive experience in commercializing bioscience research. She completed her PhD in the Faculty of Medicine at Sydney University investigating molecular models of cancer development. Her experience includes a number of years at Johnson and Johnson developing anti-HIV gene therapeutics through preclinical research to clinical trials. Her experience in early-stage start-ups includes time spent as Investment Manager with a specialist bioscience venture capital fund.

    She was appointed as Managing Director on 21 June 2002.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.0¢
Change
0.000(0.00%)
Mkt cap ! $27.06M
Open High Low Value Volume
3.0¢ 3.0¢ 3.0¢ $5.252K 175.9K

Buyers (Bids)

No. Vol. Price($)
2 707862 2.9¢
 

Sellers (Offers)

Price($) Vol. No.
3.0¢ 79328 3
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.